# Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients

> **NCT06461546** · PHASE2 · WITHDRAWN · sponsor: **Fundacion Clinic per a la Recerca Biomédica**

## Conditions studied

- Kidney Transplant Candidates

## Interventions

- **DRUG:** Imlifidase

## Key facts

- **NCT ID:** NCT06461546
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-22
- **Primary completion:** 2026-12
- **Final completion:** 2027-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to provide study drug to participants
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461546, "Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06461546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*